{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:48:56Z","timestamp":1790750936811,"version":"4.1.0"},"reference-count":38,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Elevated plasma lipoprotein (a) (Lp[a]) and cardiac events show a modest but significant association in various clinical studies. However, the influence of high Lp(a) on the gene expression in blood monocytes as a major cell involved in atherogenesis is poorly described. To identify genes influenced by elevated serum Lp(a), the gene expression was analyzed on a complementary DNA microarray comparing monocytes from a patient with isolated Lp(a) hyperlipidemia and coronary heart disease with monocytes from a healthy blood donor with low Lp(a). By using this approach, numerous genes were found differentially expressed in patient-versus-control monocytes. Verification of these candidates by Northern blot analysis or semiquantitative polymerase chain reaction in monocytes from additional patients with Lp(a) hyperlipidemia and healthy blood donors with elevated Lp(a) confirmed a significant induction of plasminogen activator inhibitor type 2 (PAI-2) messenger RNA (mRNA) in monocytes from male, but not from female, individuals with high Lp(a), indicating that this observation is gender specific. This led also to increased intracellular and secreted PAI-2 protein in monocytes from male probands with Lp(a) hyperlipidemia. Plasminogen activator inhibitor type 1 (PAI-1) mRNA was found suppressed only in the patients\u2032 monocytes and not in healthy probands with high Lp(a) levels. Purified Lp(a) induced PAI-2 mRNA and protein and reduced PAI-1 expression in monocytes isolated from various controls. The finding that PAI-2 is elevated in monocytes from male patients with isolated Lp(a) hyperlipidemia and male healthy probands with high Lp(a) and that purified Lp(a) up-regulates PAI-2 in control monocytes in vitro indicate a direct, but gender-specific, effect of Lp(a) for the induction of PAI-2 expression.<\/jats:p>","DOI":"10.1182\/blood.v97.4.981","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:40Z","timestamp":1027774000000},"page":"981-986","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":54,"title":["Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes"],"prefix":"10.1182","volume":"97","author":[{"given":"Christa","family":"Buechler","sequence":"first","affiliation":[{"name":"From the Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany; and the Institute of Medical Biochemistry, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Ullrich","sequence":"additional","affiliation":[{"name":"From the Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany; and the Institute of Medical Biochemistry, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Ritter","sequence":"additional","affiliation":[{"name":"From the Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany; and the Institute of Medical Biochemistry, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Porsch-Oezcueruemez","sequence":"additional","affiliation":[{"name":"From the Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany; and the Institute of Medical Biochemistry, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Lackner","sequence":"additional","affiliation":[{"name":"From the Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany; and the Institute of Medical Biochemistry, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Barlage","sequence":"additional","affiliation":[{"name":"From the Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany; and the Institute of Medical Biochemistry, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven Olaf","family":"Friedrich","sequence":"additional","affiliation":[{"name":"From the Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany; and the Institute of Medical Biochemistry, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert M.","family":"Kostner","sequence":"additional","affiliation":[{"name":"From the Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany; and the Institute of Medical Biochemistry, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Schmitz","sequence":"additional","affiliation":[{"name":"From the Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany; and the Institute of Medical Biochemistry, University of Graz, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021217120698200_B1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/adc.66.9.1054","article-title":"Lipoprotein (a) concentrations as risk indicators for atherosclerosis.","volume":"66","author":"Kostner","year":"1966","journal-title":"Arch Dis Child."},{"key":"2020021217120698200_B2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10408369609080056","article-title":"Lipoprotein(a) in health and disease.","volume":"33","author":"Kronenberg","year":"1996","journal-title":"Crit Rev Lab Sci."},{"key":"2020021217120698200_B3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein (a) is homologous to plasminogen.","volume":"300","author":"McLean","year":"1987","journal-title":"Nature."},{"key":"2020021217120698200_B4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0268-9499(91)90015-V","article-title":"Lipoprotein (a): the link between impaired fibrinolysis and atherosclerosis.","volume":"5","author":"Edelberg","year":"1991","journal-title":"Fibrinolysis."},{"key":"2020021217120698200_B5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.ATV.20.2.575","article-title":"Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding.","volume":"20","author":"Soulat","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2020021217120698200_B6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-0038-1642693","article-title":"Cellular receptors in the regulation of plasmin generation.","volume":"74","author":"Hajjar","year":"1995","journal-title":"Thromb Haemost."},{"key":"2020021217120698200_B7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2141.1999.01698.x","article-title":"Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis.","volume":"107","author":"Montemurro","year":"1999","journal-title":"Br J Haematol."},{"key":"2020021217120698200_B8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0955-0674(97)80126-3","article-title":"Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration.","volume":"9","author":"Chapman","year":"1997","journal-title":"Curr Opin Cell Biol."},{"key":"2020021217120698200_B9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s003950050157","article-title":"The dual role of the urokinase receptor system in pericellular proteolysis and cell adhesion: implications for cardiovascular function.","volume":"94","author":"Preissner","year":"1999","journal-title":"Basic Res Cardiol."},{"key":"2020021217120698200_B10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0167-5699(97)01121-3","article-title":"uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?","volume":"18","author":"Blasi","year":"1997","journal-title":"Immunol Today."},{"key":"2020021217120698200_B11","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/S0021-9258(18)52266-3","article-title":"Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: a potential mechanism in thrombogenesis.","volume":"266","author":"Etingin","year":"1991","journal-title":"J Biol Chem."},{"key":"2020021217120698200_B12","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1096\/fasebj.12.15.1765","article-title":"Expression of adhesion molecules by lp(a): a potential novel mechanism for its atherogenicity.","volume":"12","author":"Allen","year":"1998","journal-title":"FASEB J."},{"key":"2020021217120698200_B13","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/oxfordjournals.ndt.a027398","article-title":"Effects of lipoprotein(a) on mesangial cell proliferation and viability.","volume":"11","author":"Greiber","year":"1996","journal-title":"Nephrol Dial Transplant."},{"key":"2020021217120698200_B14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0021-9150(97)06065-6","article-title":"Altered mononuclear phagocyte differentiation associated with genetic defects of the lysosomal acid lipase.","volume":"130","author":"Rothe","year":"1997","journal-title":"Atherosclerosis."},{"key":"2020021217120698200_B15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/01.ATV.18.9.1424","article-title":"Enhanced upregulation of the Fc gamma receptor IIIa (CD16a) during in vitro differentiation of ApoE4\/E4 monocytes.","volume":"18","author":"Stoehr","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2020021217120698200_B16","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/01.ATV.13.6.944","article-title":"Functionally abnormal monocytes in hypercholesterolemia.","volume":"13","author":"Stragliotto","year":"1993","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2020021217120698200_B17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/01.ATV.16.12.1437","article-title":"Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia.","volume":"16","author":"Rothe","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2020021217120698200_B18","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0022-2275(20)39127-6","article-title":"Characterization of inherited scavenger receptor over-expression and abnormal macrophage phenotype in a normolipidemic subject with planar xanthoma.","volume":"37","author":"Giry","year":"1996","journal-title":"J Lipid Res."},{"key":"2020021217120698200_B19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-0037-1614531","article-title":"Increased expression of u-PA and u-PAR on monocytes by LDL and Lp(a) lipoproteins\u2014consequences for plasmin generation and monocyte adhesion.","volume":"81","author":"Ganne","year":"1999","journal-title":"Thromb Haemost."},{"key":"2020021217120698200_B20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0021-9150(95)05790-0","article-title":"Oxidized lipoprotein (a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells.","volume":"123","author":"Ragab","year":"1996","journal-title":"Atherosclerosis."},{"key":"2020021217120698200_B21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood.V94.3.837.413k02_837_844","article-title":"Serial analysis of gene expression in human monocytes and macrophages.","volume":"94","author":"Hashimoto","year":"1999","journal-title":"Blood."},{"key":"2020021217120698200_B22","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1073\/pnas.94.6.2150","article-title":"Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.","volume":"94","author":"Heller","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217120698200_B23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0955-3886(96)90086-7","article-title":"Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease.","volume":"4","author":"Ullrich","year":"1996","journal-title":"Transfus Sci."},{"key":"2020021217120698200_B24","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0022-2275(20)32100-3","article-title":"Preparation of a stable fresh frozen primary lipoprotein(a) (Lp(a)) standard.","volume":"40","author":"Kostner","year":"1999","journal-title":"J Lipid Res."},{"key":"2020021217120698200_B25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent.","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem."},{"key":"2020021217120698200_B26","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1021\/bi00591a005","article-title":"Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.","volume":"18","author":"Chirgwin","year":"1979","journal-title":"Biochemistry."},{"key":"2020021217120698200_B27","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1001\/jama.1986.03380180102027","article-title":"Lp(a) lipoprotein as a risk factor for myocardial infarction.","volume":"256","author":"Rhoads","year":"1986","journal-title":"JAMA."},{"key":"2020021217120698200_B28","first-page":"21","article-title":"Lipoprotein(a) in renal disease.","volume":"30","author":"Kronenberg","year":"1996","journal-title":"Am J Kidney Dis."},{"key":"2020021217120698200_B29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.ATV.11.3.629","article-title":"Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator: in vitro studies in a plasma milieu.","volume":"11","author":"Rouy","year":"1991","journal-title":"Arterioscler Thromb."},{"key":"2020021217120698200_B30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00041433-199906000-00005","article-title":"Lipoprotein(a): intrigues and insights.","volume":"10","author":"Hobbs","year":"1999","journal-title":"Curr Opin Lipidol."},{"key":"2020021217120698200_B31","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1161\/01.ATV.18.12.1983","article-title":"Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes.","volume":"18","author":"Han","year":"1998","journal-title":"Arterioscler Throm Vasc Biol."},{"key":"2020021217120698200_B32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-89-2-157","article-title":"Menopause and coronary heart disease: the Framingham Study.","volume":"89","author":"Gordon","year":"1978","journal-title":"Ann Intern Med."},{"key":"2020021217120698200_B33","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1182\/blood.V86.11.4007.bloodjournal86114007","article-title":"Biological and clinical aspects of plasminogen activator inhibitor type 2.","volume":"86","author":"Kruithof","year":"1995","journal-title":"Blood."},{"key":"2020021217120698200_B34","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.1016\/S0021-9258(19)50541-5","article-title":"Regulation of plasminogen activator inhibitor mRNA levels in lipopolysachcaride-stimulated human monocytes.","volume":"267","author":"Schwartz","year":"1992","journal-title":"J Biol Chem."},{"key":"2020021217120698200_B35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-0037-1614425","article-title":"Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin.","volume":"81","author":"Ritchie","year":"1999","journal-title":"Thromb Haemost."},{"key":"2020021217120698200_B36","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1182\/blood.V74.4.1396.1396","article-title":"Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors.","volume":"74","author":"Kirchheimer","year":"1989","journal-title":"Blood."},{"key":"2020021217120698200_B37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1073\/pnas.92.1.205","article-title":"Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid\/scid mice.","volume":"92","author":"Mueller","year":"1995","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021217120698200_B38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm0898-923","article-title":"Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.","volume":"4","author":"Bajou","year":"1998","journal-title":"Nat Med."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/4\/981\/1671079\/h8040100981.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/4\/981\/1671079\/h8040100981.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T09:20:25Z","timestamp":1622020825000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/97\/4\/981\/53062\/Lipoprotein-a-upregulates-the-expression-of-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,15]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v97.4.981","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2,15]]}}}